Live Webinar

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Hosted by AJMC and Targeted Oncology

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
Publication|Articles|November 1, 2024

Evidence-Based Oncology

  • November 2024
  • Volume 30
  • Issue 12

Table Multiple Myeloma Trials November 2024

Key Takeaways

TABLE. Multiple Myeloma: Enrollment of Black Patients in Trials Required for Initial FDA Approval

TABLE

Articles in this issue

over 1 year ago

To Improve Clinical Trial Equity in Multiple Myeloma, Just Ask

over 1 year ago

Collaborating for Cancer Care Equity: Community and Academic Insights

over 1 year ago

Elevating Value in Cancer Care With Innovations, Accessibility, Equity

over 1 year ago

Innovating Cancer Care Through Equity and AI: Vanderbilt’s Vision

over 1 year ago

Advancing Equitable Access to Elevate Value-Based Cancer Care

over 1 year ago

Putting Patients First by Extending the Reach of World-Class Care

over 1 year ago

As Myeloma Trials Tackle Frontline Treatment, Where Are the Black Patients?

over 1 year ago

SPOTLIGHT: What the Approval of Isatuximab Plus VRd Means to Multiple Myeloma Care

almost 2 years ago

NCCN Guidelines for MPN Reflect New Drugs, Focus on Clinical Trials

almost 2 years ago

CRC Screening Increases in Patients Aged 45 to 49 After USPSTF Recommendation